MedPath

Neomycin and Polymyxin B Sulfates and Hydrocortisone

Neomycin and Polymyxin B Sulfatesand Hydrocortisone Otic Suspension USP

Approved
Approval ID

595ee3ac-2f33-4459-87ff-be002928059c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 8, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone

PRODUCT DETAILS

NDC Product Code21695-438
Application NumberANDA064053
Marketing CategoryC73584
Route of AdministrationAURICULAR (OTIC)
Effective DateOctober 9, 2008
Generic NameNeomycin sulfate, Polymyxin B Sulfate and Hydrocortisone

INGREDIENTS (9)

HYDROCORTISONEActive
Quantity: 10 mg in 1 mL
Code: WI4X0X7BPJ
Classification: ACTIB
NEOMYCIN SULFATEActive
Quantity: 3.5 mg in 1 mL
Code: 057Y626693
Classification: ACTIB
cetyl alcoholInactive
Code: 936JST6JCN
Classification: IACT
POLYMYXIN B SULFATEActive
Quantity: 10000 mg in 1 mL
Code: 19371312D4
Classification: ACTIB
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
sulfuric acidInactive
Code: O40UQP6WCF
Classification: IACT
thimerosalInactive
Code: 2225PI3MOV
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Neomycin and Polymyxin B Sulfates and Hydrocortisone - FDA Approval | MedPath